(Q22252197)

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Host metalloproteinases in Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

An epidemic of oligoarticular arthritis in children and adults in three connecticut communities

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Intracellular persistence of Borrelia burgdorferi in human synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

1 reference

7 January 2021

Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Chemokines and Toll-like receptors in Lyme disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Mechanism of action of hydroxychloroquine as an antirheumatic drug

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Elucidation of Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

A Critical Appraisal of “Chronic Lyme Disease”

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Reinfection in patients with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Response to meta-analysis of Lyme borreliosis symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Development of autoimmunity in Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Lyme disease-a tick-borne spirochetosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Diagnosis of lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Lyme arthritis: radiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Decline in the Frequencies of Borrelia burgdorferi OspA161-175-Specific T Cells after Antibiotic Therapy in HLA-DRB1*0401-Positive Patients with Antibiotic-Responsive or Antibiotic-Refractory Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Borrelia burgdorferi in joint fluid in chronic Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

The clinical evolution of Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

The persistence of spirochetal nucleic acids in active Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

The polymerase chain reaction assay for Borrelia burgdorferi in the diagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum

1 reference

https://api.crossref.org/works/10.1016%2FJ.IDC.2007.12.014

7 January 2021

10.1016/J.IDC.2007.12.014

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2532544

2532544

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference